CHEMOTHERAPY EFFECT

This study tests whether adding treatment for H. pylori infection to standard chemotherapy (oxaliplatin and S-1) before and after surgery can help shrink tumors more effectively in people with locally advanced stomach or gastroesophageal junction cancer. About 198 participants wi…

This study is for people with a type of liver cancer (intrahepatic cholangiocarcinoma) that cannot be removed by surgery. It compares two treatments delivered directly to the liver's blood supply—HAI-FUDR/DEX and SIRT—both given alongside standard chemotherapy. The goal is to shr…

This study tests whether adding chemotherapy to a combination of two drugs (camrelizumab and apatinib) helps people with advanced liver cancer live longer without their disease getting worse. About 326 adults with liver cancer that cannot be removed by surgery will be randomly as…

This study looks at whether adding immunotherapy or targeted drugs to standard chemoradiotherapy can help people with esophageal or esophagogastric junction cancer live longer. It involves 2,000 adults with stage I to IVa cancer who are not able to have surgery. The goal is to fi…

This study tests whether adding silibinin (a liver-protecting supplement from milk thistle) to standard chemotherapy can improve outcomes for adults newly diagnosed with a common type of acute myeloid leukemia (non-M3). About 100 participants will receive either standard chemo al…

This phase 3 trial tests two different ways to give chemotherapy combined with immunotherapy and a targeted drug for people with advanced liver cancer (BCLC stage C). One group gets standard IV chemo, the other gets chemo directly into the liver artery. The goal is to see which a…

This study aims to find the best treatment before surgery for esophageal cancer. It compares chemotherapy, chemoradiation, targeted therapy, and immunotherapy in 2000 adults with stage I-IVa disease. The goal is to improve survival and reduce side effects.

This study looks at whether massage therapy can improve sleep for children and teens (ages 12-21) who are in the hospital for cancer treatment or a stem cell transplant. Researchers will compare sleep minutes and quality between those who get standard care and those who also rece…

This study tests whether a mobile app can reduce memory and thinking problems (often called 'chemobrain') caused by chemotherapy in women with gynecologic cancers. About 64 participants will use the app and have their brain function tested. The goal is to see if this simple, at-h…

This study looks at whether a 16-week high-intensity interval training (HIIT) program can help women with breast cancer maintain their thinking and memory skills while undergoing chemotherapy. About 30 women will be enrolled and will have their brain function, heart fitness, and …

This study looks at whether socio-aesthetics (specialized beauty and skincare sessions) can help lower anxiety in people starting chemotherapy for cancer. About 192 patients who have never had chemo before will receive these sessions alongside their treatment. Researchers will me…